Last reviewed · How we verify
SODIUM PHENYLACETATE — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
SODIUM PHENYLACETATE (SODIUM PHENYLACETATE). Sodium phenylacetate and sodium benzoate provide alternative pathways for nitrogen disposal in patients with urea cycle disorders.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| SODIUM PHENYLACETATE TARGET | SODIUM PHENYLACETATE | marketed | 1987-01-01 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- SODIUM PHENYLACETATE CI watch — RSS
- SODIUM PHENYLACETATE CI watch — Atom
- SODIUM PHENYLACETATE CI watch — JSON
- SODIUM PHENYLACETATE alone — RSS
Cite this brief
Drug Landscape (2026). SODIUM PHENYLACETATE — Competitive Intelligence Brief. https://druglandscape.com/ci/sodium-phenylacetate. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing